IllumiSonics Inc., FUJIFILM Visualsonics, Inc .and iThere Medical are Dominating the Global Photoacoustic Imaging Market in 2021

Global Photoacoustic Imaging Market is expected to grow with the CAGR of 16.8 % in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-photoacoustic-imaging-market

Global photoacoustic imaging is a highly fragmented market, which includes number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global photoacoustic imaging market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

  • In September 2019, illumiSonics Inc. had announced their first developed label free, non-contact in vivo imaging of ocular vasculature by using PARS microscopy. It can help in diagnosis and treatment of ocular diseases. This development will help the company to leave its footprint in the market.

IllumiSonics Inc is the dominating player in global photoacoustic imaging market. The other key players existing in the market includes PreXion, iThera Medical, PST Inc., HÜBNER Photonics, Litron Lasers, FUJIFILM Visualsonics, Inc., kibero, InnoLas Laser GmbH, QUANTEL LASER, BK Medical Holding Company, Inc., EKSPLA, TomoWave Laboratories, Inc., Aspectus GmbH, Daylight Solutions, ADVANTEST CORPORATION, OPOTEK LLC, NanoHybrids, Seno Medical Instruments, Inc. and Vibronix, Inc. among others.

Photoacoustic Imaging MarketIllumiSonics Inc.

The company was founded in the year 2014 and it is headquartered in Toronto, Canada of North America. The company is focused in producing advanced photoacoustic imaging technologies for both clinical and preclinical applications. The company offers a distinct product category known as PARS which is also the market focused category.

For instance,

  • In October 2020, the company had upgrated its photoacoustic remote sensing microscopy that can help to maximize the safety in brain tumour surgery, as this imaging can help to differentiate gliosis from healthy tissue, necrotic from living tissue and white from gray material. This development will help the company to set a new benchmark in market.

The company offers services in all over the Canada region.

FUJIFILM Visualsonics, Inc.

The company was founded in 1999 and is headquartered in Toronto, Canada. The company offers different ultrasound technologies based oh photoacoustic imaging system for all diagnostic applications. The company offer various product categories such as preclinical, clinical, acoustics and engineering out of which both are market focused categories.

For instance,

  • In November 2020, FUJIFILM Visualsonics, Inc. had its first installation of the Vevo F2 Equipped with Vevo Advanced Data Acquisition (VADA), the Vevo F2 allows access to pre-beam formed individual channel data via an all new, easy-to-use, graphical user interface. With full control over transmit profiles, researchers have the power and freedom to develop and explore new imaging methods in a quick, iterative fashion—going beyond existing imaging modes.

The company has presence across the globe in North America, Europe and Asia-Pacific region.

iThere Medical

The company was founded in 2010 with headquarter based in Munich, Germany of Europe. The primary focus of the company is to provide all range of imaging system which is applicable for clinical and pre-clinical applications. The company offer various product categories such as preclinical research, clinical research, out of which both are market focused categories.

For instance,

  • In March 2020, it is found in a study published in Nature Biomedical Engineering, raster-scanning optoacoustic mesoscopy (RSOM) of iThera Medical had provided an unprecedented means of studying tumor vasculature. Localized therapies provide appealing opportunities to delay tumor growth or even remove existing masses without damaging normal tissue in the ongoing quest for new and improved ways to cure cancer. With this product, the company had revealed several processes behind this therapy, which were unidentified and thereby, benefited the company in making a brand into the competitive market.

The global presence of the company is all over the Germany and they offers wide range of services for the photoacoustic imaging system market.